Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
The prevalence and cost of unapproved uses of top-selling orphan drugs.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
The prevalence and cost of unapproved uses of top-selling orphan drugs.
The prevalence and cost of unapproved uses of top-selling orphan drugs. PLoS One. 2012; 7(2):e31894.
View in:
PubMed
subject areas
Benzhydryl Compounds
Costs and Cost Analysis
Drug Approval
Humans
Lidocaine
Naphthalenes
Neuralgia
Off-Label Use
Orphan Drug Production
Prescription Drugs
Public Health
United States
United States Food and Drug Administration
authors with profiles
Daniel Hal Solomon, M.D.
Aaron Seth Kesselheim, M.D.
Jerome Lewis Avorn, M.D.
Jessica Myers Franklin, Ph.D.